This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stocks to Watch: FedEx, Lululemon, Dollar General (Update 1)

NEW YORK -- FedEx (FDX), the package delivery giant, reported earnings of $1.65 per share for its third quarter ended Feb. 29.

Excluding one-time items, earnings were $1.55 per share and revenue was up 9% from the previous year to $10.56 billion.

Analysts expected profit of $1.35 a share on revenue of $10.6 billion.

Shares were down 0.3% to $95.50 in premarket trading on Thursday.


Lululemon Athletica (LULU) saw a 34% rise in fourth-quarter profit to $73.52 million, or 51 cents a share, on revenue of $371.52 million, up 29% from a year earlier.

Analysts polled by Thomson Reuters were looking for profit of 49 cents a share on revenue of $362.42 million.

The athletic retailer's revenue projection for the fiscal first quarter was $265 million to $270 million, ahead of estimates of $257.46 million.

Shares were down almost 2% at $72.60 in premarket trading.


Dollar General (DG) said earnings rose 31% in the fiscal fourth quarter.

Profit came in at $292.5 million, or 85 cents a share, ahead of analysts' estimates of 82 cents. Revenue of $4.19 billion was slightly higher than the forecast of $4.11 billion.

The company said it expects earnings of $2.65 to $2.75 a share for the year, in line with Wall Street's forecast for $2.71 a share.

Shares were trading up 1.2% at $45.30.


McDonald's (MCD) CEO Jim Skinner will step down on June 30 and hand the reigns of the world's largest hamburger chain to President Donald Thompson.

Skinner has been CEO since 2004.

Thompson, 48 years old, has long been considered among the top candidates in line to succeed Skinner. He has been with McDonald's for 22 years. He will be the first African American to head McDonald's.

Shares were down 0.5% to $96.20.


Nike (NKE) will report third-quarter earnings after the close Thursday. Analysts are looking for earnings of $1.41 a share, up 7.4% from a year earlier. Sales are expected at $6.59 billion, up from $5.6 billion in the period a year earlier.

Shares were down 0.2% to $110.22.


Watson Pharmaceuticals (WPI) on Wednesday was reportedly close to buying its drug maker competitor Actavis in a deal worth €4.5 billion.

According to the Wall Street Journal , which cited people familiar with the matter, the U.S. generic drug maker is the only company trying to buy the Swiss company. A transaction may happen after Easter, said the report.

Actavis ranks No. 4 in sales of generic drugw around the world and would help Watson expand its footprint in Europe.

Shares of Watson were edging lower at 0.1% to $63.65 in premarket trading.


Discover Financial Services (DFS), the credit card company, topped analysts' first-quarter earnings expectations.

Discover reported net income of $631 million, or $1.18 a share, for the three months ended in February; analysts were expecting a profit of 94 cents a share. Revenue came in at $1.84 billion, slightly above analysts' estimates of $1.82 billion.

Shares were down 1.1% to $31.30.

-- Written by Joseph Woelfel and Chao Deng

>To contact the writer of this article, click here: Joseph Woelfel

Related links:
5 Earnings Stocks Poised to Pop


5 Stocks That Could Be Trampled

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,927.49 -33.08 -0.20%
S&P 500 1,974.79 -3.55 -0.18%
NASDAQ 4,434.1480 -15.4160 -0.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs